Ocular adnexal lymphoma - A single-center observational study of survival outcomes

Indian J Ophthalmol. 2025 Feb 1;73(2):261-266. doi: 10.4103/IJO.IJO_110_24. Epub 2024 Dec 27.

Abstract

Purpose: This study aims to comprehensively characterize the clinical, demographic, and histopathological features of ocular adnexal lymphoma (OAL) and assess their impact on patients' survival outcomes.

Methods: A total of 123 patients were included in the study; of these, 93 patients were selected for survival analysis. Survival data were analyzed using the Kaplan-Meier test, and correlation was assessed through the log-rank test and Cox regression analysis.

Results: The median age at presentation was 56 years. Furthermore, 98% of patients had primary OAL. The orbit was the most common site of involvement. The majority of patients were of B-cell origin (98%), and only 2% of patients had T-cell lymphoma. In addition, 83% of patients were treated with chemotherapy, and with a median follow-up of 38 months, complete remission was achieved in 48% of patients. The median progression-free survival was 26.4 months. The presence of disseminated disease was strongly linked to an unfavorable prognosis ( P < 0.001) and reduced survival ( P = 0.037).

Conclusion: The 5-year overall survival of the entire study cohort was 81%. The prognosis for OAL is found to be favorable, but the presence of dissemination serves as a notable predictor for poor prognosis.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Eye Neoplasms / diagnosis
  • Eye Neoplasms / mortality
  • Eye Neoplasms / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • India / epidemiology
  • Intraocular Lymphoma / diagnosis
  • Intraocular Lymphoma / drug therapy
  • Intraocular Lymphoma / mortality
  • Intraocular Lymphoma / therapy
  • Male
  • Middle Aged
  • Orbital Neoplasms* / mortality
  • Prognosis
  • Retrospective Studies
  • Survival Rate / trends
  • Young Adult